Camelpox: Epidemiology, diagnosis and control measures

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 10, 2010, Pages 1187-1201

  Bhanuprakash, Veerakyathappa ^a   Prabhu, Manimuthu ^a   Venkatesan, Gnanavel ^a   Balamurugan, Vinayagamurthy ^b   Hosamani, Madhusudan ^a   Pathak, Krishna M L ^c   Singh, Raj Kumar ^d  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^b Project Directorate Animal Disease Monitoring and Survelience   (India)

^c NATIONAL RESEARCH CENTRE ON CAMEL   (India)

^d NATIONAL RESEARCH CENTRE ON EQUINES   (India)

Author keywords

camelpox; camels; diagnosis; epidemiology; immunity; poxvirus; vaccine; zoonosis

Indexed keywords

9 (3 HYDROXY 2 PHOSPHONOMETHOXYPROPYL)ADENINE; CIDOFOVIR; CIDOFOVIR 3 HEXADECYLOXYPROPYL ESTER; DEXTRAN SULFATE; DUCAPOX; IMATINIB; INACTIVATED VIRUS VACCINE; INOSINATE DEHYDROGENASE INHIBITOR; JOUF 78; LIVE VACCINE; METISAZONE; ORTHOVAC; PROTEIN INHIBITOR; RIBAVIRIN; RIFAMPICIN; SMALLPOX VACCINE; ST 246; TTP 6171; UNCLASSIFIED DRUG; VACCINE; VESTIDE; VIRUS VACCINE;

ACTIVE IMMUNIZATION; ANTIVIRAL THERAPY; ARTIODACTYLA; AUTOPSY; BLOOD ANALYSIS; CAMEL; CAMELPOX; CELLULAR IMMUNITY; CLINICAL FEATURE; DISEASE ACTIVITY; DRUG ABSORPTION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC CODE; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; INFECTION CONTROL; MORTALITY; NONHUMAN; POXVIRUS; POXVIRUS INFECTION; PUBLIC HEALTH PROBLEM; PUBLIC HEALTH SERVICE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; REVIEW; SEROLOGY; SEX DIFFERENCE; SKIN INFECTION; SMALLPOX; SOMALIA; TRANSMISSION ELECTRON MICROSCOPY; VIRUS CHARACTERIZATION; VIRUS GENOME; VIRUS INFECTION; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS STRAIN; VIRUS TRANSMISSION; WESTERN BLOTTING;

ANIMALS; CAMELS; CELL LINE; HOST SPECIFICITY; HUMANS; ORTHOPOXVIRUS; POLYMERASE CHAIN REACTION; POXVIRIDAE INFECTIONS; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 77958472706     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.105     Document Type: Review

References (166)

1. Azwai SM, Carter SD, Woldehiwet Z. Monoclonal antibodies against camel (Camelus dromedarius) IgG, IgM and light chains. Vet. Immunol. Immunopathol. 45, 175-184 (1995).
2. OIE Manual. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 6th Edition. Volume 2, Chapter 2.7.14. OIE, France (2008).
3. Wernery U, Kaaden OR. Camel pox. In: Infectious Diseases in Camelids, Second Edition. Wernery U, Kaaden OR (Eds). Blackwell Science Berlin, Vienna, 176-185 (2002).
4. Leese S. Two diseases of young camels. J. Trop. Vet. Sci. 4, 1 (1909).
5. Hafez SM, Al-Sukayran A, dela Cruz D et al. Development of a live cell culture camelpox vaccine. Vaccine 8(10), 533-539 (1992).
6. Jezek Z, Kriz B, Rothbaur V. Camelpox and its risk to the human population. J. Hyg. Epi. Microbio. Immunol. 27, 29-42 (1983).
7. Al-Ziabi O, Nishikawa H, Meyer H. The first outbreak of camelpox in Syria. J. Vet. Med. Sci. 69(5), 541-543 (2007).
8. Davies FG, Mungai JN, Shaw T. Characteristics of a Kenyan camelpox virus. J. Hyg 7, 381-385 (1975).
9. Kriz B. A study of camelpox in Somalia. J. Comp. Pathol. 92, 1-8 (1982).
10. ICTV. Virus Taxonomy: 8th Report of the International Committee on Taxonomy of Viruses. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA. (Eds), 123, Academic Press (2005).
11. Mahnel H, Bartenbach G. Classification of camelpox virus (CPV). Zentralbl Veterinarmed B. 20(7), 762-766 (1973).
12. Baxby D. Smallpox viruses from camels in Iran. Lancet 7786, 1063-1065 (1972).
13. Fenner F, Wittek R, Dumbell KR. The Orthopoxviruses. Academic Press Inc., Harcourt Brace Jovanovich, NY, USA (1989).
14. Bedson HS. Camelpox and smallpox. Lancet 2, 1253 (1972).
15. Baxby D. Differentiation of smallpox and camelpox viruses in cultures of human and monkey cells. J. Hyg. 72, 251-254 (1974).
16. Esposito JJ, Knight JC. Orthopoxvirus DNA: a comparison of restriction profles and maps. Virology 143, 230-251 (1985).
17. Baxby D, Ramyar H, Hessami M, Ghaboosi B. A comparison of the response of camels to intradermal inoculation with camelpox and smallpox viruses. Infect. Immun. 11, 617-621 (1975).
18. Gubser C, Smith GL. The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. J. Gen. Virol. 83(4), 855-872 (2002).
19. Sheikh Ali HM, Khalafalla AI, Nimir AH. Detection of camel pox and vaccinia viruses by polymerase chain reaction. Trop. Anim. Health. Prod. 41(3), 393-396 (2009).
20. Afonso CL, Tulman ER, Lu Z et al. The genome of camelpox virus. Virology 295(1), 1-9 (2002). • Delineates the genomic organization of camelpox virus (CMLV) and its comparison with orthopoxviruses (OPXVs).
21. Borisovich YuF. Camel pox. Ospa verblyudov, Variola camelina. In: Maloizvestnye Zaraznye Bolezni Zhivotnykh (Little-Known Contagious Diseases of Animals) Orlov FM (Ed.). Izdatelstvo Kolos, USSR, 2nd Edition, 32-42 (Ru) (1973).
22. Duraffour S, Snoeck R, Krecmerova M et al. Activities of several classes of acyclic nucleoside phosphonates against camelpox virus replication in different cell culture models. Antimicrob. Agents Chemother, 51(12), 4410-4419 (2007).
23. Moss B. Poxviridae: the viruses and their replication. In: Field's Virology, Fourth Edition. Knipe DM, Howley PM (Eds). Lippincott Williams and Wilkins, Philadelphia, PA, USA, 2849-2883 (2001).
24. Murphy FA, Gibbs E P J, Horzinek MC, Studdert MJ. Veterinary Virology. 3rd Edition. Academic Press, San Diego, CA, USA, 282 (1999).
25. Engelstad M, Smith GL. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egressof extracellular virus and for virus virulence. Virology 194, 627-637 (1993).
26. Isaacs SN, Wolffe EJ, Payne LG, Moss B. Characterization of a vaccinia virusencoded 42-kilodalton classI membrane glycoprotein component of the extracellular virus envelope. J. Virol. 66, 7217-7224 (1992).
27. Martinez-Pomares L, Stern RJ, Moyer RW The ps/hr gene (B5R open reading frame homolog) of rabbitpox virus controls pock color, is a component of extracellular enveloped virus, and is secreted into the medium. J. Virol. 67, 5450-5462 (1993).
28. Balamurugan V, Bhanuprakash V, Hosamani M, Srinivasan VA, Singh RK. Comparative sequence analyses of B5R gene of Indian camelpox virus isolates with other orthopoxviruses. Indian J. Virol. 19(20), 34-38 (2008). • Discusses sequence and phylogenetic analysis of Indian virus camelpox isolates based on the envelope protein gene, B5R, and their relation to other OPXVs.
29. Tantawi HH, Saban MS, Reda IM, El-Dahaby H. Camelpox virus in Egypt I-isolation and characterization. Bull. Epizoot. Dis. Africa. 22(4), 315-319 (1974).
30. Al-Falluji MM, Tantawi HH, Shony MO. Isolation, identification and characterization of camelpox virus in Iraq. J. Hyg. Camb. 83, 267-272 (1979).
31. Khalafalla AI, Mohamed M E H, Ali BH. Camel pox in the Sudan and its isolation and identification of the causative virus. J. Camel Pract. Res. 5(2), 229-233 (1998).
32. Coetzer J A W. Poxviridae. In: Infectious Diseases of Livestock, Second Edition. Coetzer JAW, Tustin RC (Eds). Oxford University Press, Southern Africa, 2, 1265-1267 (2004).
33. Buchnev KN, Sadykov RG. On camelpox in Kazakhstan (in Russian 1. Tr. Nauchnoissledov). Vet. Instituta Alma-Ata 15, 12 (1969).
34. Wilson RT, Araya A, Melaku A. The one humped camel. An analytical and annoated Bibliography 1980-1989. Animal Production and Health Section, Joint FAO/IAEA, Division for Nuclear Techniques in Food and Agriculture, Wien, Austria (1990).
35. Davies FG, Mbugua H, Atema C, Wilson A. The prevalence of antibody to camelpox virus in six different herds in Kenya. J. Comp. Path. 95, 633-635 (1985).
36. Munz E, Kropp E, Reimann M. Demonstration of antibodies against Orthopoxvirus cameli in sera of East African dromedaries by ELISA. J. Vet. Med. B. 3, 221-230 (1986).
37. Fassi-Fehri MM. Diseases of camels. Rev. Sci. Tech. Off. Int. Epiz. 6, 337-354 (1987).
38. Ramyar H, Hessami M. Isolation, cultivation and characterisation of camelpox virus. Zentralblatt fur Veterinarmedizin. 19(3), 182-189 (1972).
39. Higgins AJ, Silvey RE, Abdelghafr AE, Kitching RP. The epidemiology and control of an outbreak of camelpox in Bahrain. Proc. 1st. Int. Camel Conf. 101-104 (1992).
40. Kaaden OR, Walz A, Czerny CP, Wernery U. Progress in the development of a camelpox vaccine. Proc. 1st. Int. Camel Conf. 47-49 (1992).
41. Al Hendi AB, Abuelzein EM, Gameel AA, Hassanein MM. A slow-spreading mild form of camelpox infection. J. Vet. Med. B. 41, 71-73 (1994).
42. Marrenikova SS, Shenkman LS, Shelukhina EM, Malsova NN. Isolation of camelpox virus and investigation of its properties. Acta Virol. 18, 423-428 (1974). • Depicts the epidemiology of camelpox infection.
43. Chauhan RS, Kaushik RK. Isolation of camelpox virus in India. Br. Vet. J. 143, 581-582 (1987). • Depicts the first successful isolation and identification of CMLV in India.
44. Pfahler W H E, Munz E. Camelpox. Int. J. Anim. Sci. 4, 109-114 (1989).
45. Hafez SM, Eissa YM, Amjad AM, Al-Sharif AK, Al-Sukayran A, dela Cruz D. Preliminary studies on camelpox in Saudi Arabia. In: Programme and Abstracts of the 9th Symposium on the Biological Aspects of Saudi Arabia, Riyadh. March (1986).
46. Abu Alzein EM, Gameel AA, Ramadan RO, Housawi FM. An eruptive moderate form of camelpox infection in dromedary camels (Camelus dromedarius) in Saudi Arabia. Rev. Sci. Tech. 18, 749-752 (1999).
47. Al-Ani M O A, Al-Salihy RA. Camelpox in Iraq. Bull. Anim. Hlth. Prod. Afr. 36, 394-397 (1988).
48. Hussein MF, Al-Mufarrej SL. Some clinicopathological aspects of camelpox in Saudi Arabia. J. king. Saud. Univ., Agric. Sci. 11(2), 113-120 (1999).
49. Ommer Dafalla MA, Abdelhamid Elfadil AM. Epidemiologic and clinical features of camelpox in Jazan region, Saudi Arabia. Vet. Res. 1(3), 65-67 (2007).
50. Pfeffer M, Meyer H, Wernery U, Kaaden OR. Comparison of camelpox viruses isolated in Dubai. Vet. Microbiol. 49, 135-146 (1996).
51. Odend'Hal S. The Geographical Distribution of Animal Viral Diseases. Academic Press, NY, USA, 99 (1983).
52. Chauhan RS, Kulshreshtha RC, Kaushik RK. Epidemiological studies of viral diseases of livestock in Haryana State. Ind. J. Virol. 1(1), 10-16 (1985).
53. Chauhan RS, Kaushik RK, Gupta SC, Satiya KC, Kulshreshtha RC. Prevalence of differential diseases in camels (Camelus dromedaries) in India. Camel New letter 3, 10-14 (1986).
54. Khanna ND, Uppal PK, Sharma N, Tripathi BN. Occurrence of pox infections in camels. Ind. Vet. J. 73(8), 813-817 (1996).
55. Renner-Muller IC, Meyer H, Munz E. Characterization of camelpox virus isolates from Africa and Asia. Vet. Microbio. 45, 371-381 (1995).
56. Schwartz, Sabine, Schwartz HJ, Wilson AJ. Eine fotographische Dokumentation wishtiger Kamelkrankheiten in Kenia. Der. Prakt. Tierarzt. 11, 985-989 (1982).
57. Kropp EM. Kamelpocken-eine synoptische Darstellung sowie der Nachweis von Antikorpern in ostafrikanischen Dromedarseren mit einem ELISA. Vet. Med. Diss. Munchen, Germany (1985).
58. Gitao CG. An investigation of camelpox outbreaks in two principal camel (Camelus dromedarius) rearing areas of Kenya. Rev. Sci. Tech. 16, 841-847 (1997).
59. Richard D. Manuel des maladies du dromadaire. Projet de derveloppement de l'elevage dans le Niger centre-est. Maisons Alfort, IEMVT (1986).
60. Nguyen-ba-vy, Richard D, Gillet JP. Characterization of an orthopoxvirus of camels from Niger. Rev. Elev. Med. Vet. Pays Trop. 42, 19-25 (1989).
61. Shommein AM, Osman AM. Diseases of camels in the Sudan. Rev. Sci. Tech. Off. Int. Epiz. 6, 481-484 (1987).
62. Roslyakov AA. Comparative ultrastructure of camelpox virus, the virus of a pox-like disease of camels ('auzdyk') and contagious ecthyma virus. Vopr. Virusol. 17, 26-30 (1972).
63. Buchnev KN, Tulepbaev SZ, Sansyzbaev AR. Infectious diseases of camels in the USSR. Revue. Sci. Tech. 6, 487-495 (1987).
64. Champak Bhakat, Chaturvedi D, Raghavendra S, Nagpaul PK. Studies on camel management under various microenvironment of shelter systems. Indian J. Dairy Sci. 57(5), 347-353 (2004).
65. Azwai SM, Carter SD, Woldehiwet Z, Wernery U. Serology of Orthopoxvirus cameli infection in dromedary camels: analysis by ELISA and western blotting. Comp. Immunol. Microbiol. Infect. Dis. 19(1), 65-78 (1996).
66. Khalafalla AI, Mohamed M E H, Agab H. Serological survey in camels of the Sudan for prevalence of antibodies to camelpox virus using ELISA technique. J. Camel Pract. Res. 5(2), 197-200 (1998).
67. Mayer A, Czerny CP. Camelpox virus. In: Virus Infections of Vertebrates. Vol. 3, Virus Infections of Ruminants, Dinter Z. Morein B (Eds). Elsevier Science Publisher BV, Amsterdam, Oxford, New York, Tokyo, 19-22 (1990).
68. Nothelfer HB, Wernery U, Czerny CP. Camel pox: antigen detection within skin lesions-immunohistochemistry as a simple method of etiological diagnosis. J. Camel Pract. Res. 2(2), 119-121 (1995).
69. Wernery U, Kaaden OR, Ali M. Orthopox virus infections in dromedary camels in United Arab Emirates (U. A. E.) during winter season. J. Camel Pract. Res. 4(1), 51-55 (1997). (Pubitemid 127532680)
70. Wernery U, Meyer H, Pfeffer M. Camel pox in the United Arab Emirates and its prevention. J. Camel Pract. Res. 4(2), 135-139 (1997). (Pubitemid 127531930)
71. Bhanuprakash V, Balamurugan V, Hosamani M et al. Isolation and characterization of Indian isolates of camel pox virus. Trop. Anim. Health Prod. DOI: 10.1007/s11250-010-9560-z (2010) (Epub ahead of print).
72. Khalfalla AI, Mohamed M E M. Camel pox in the Sudan. J. Camel Prac. Res. 5(2), 235-238 (1998).
73. Borisovich YF, Orekhov MD. Camel pox. Veterinariya (Moscow) 3, 50-52 (1966).
74. Khalafalla AI, Mohamed M E H. Clinical and epizootiological features of camelpox in eastern Sudan. J. Camel Prac. Res. (2), 99-102 (1996).
75. Pfeffer M, Neubauer H, Wernery U, Kaaden OR, Meyer H. Fatal form of camelpox virus infection. Vet. J. 155, 107-109 (1998).
76. Yager JA, Scott DW, Wilcock BP. Viral diseases of the skin. In: Pathology of Domestic Animals, Fourth Edition. Jubb KVF, Kennedy PC, Palmer N (Eds). Academic Press, San Diego, USA, 629-644 (1991).
77. Kinne J, Cooper JE, Wernery U. Pathological studies on camelpox lesions of the respiratory system in the United Arab Emirates (UAE). J. Comp. Pathol. 118, 257-266 (1998).
78. Wernery U, Zachariah R. Experimental camel pox infection in vaccinated and unvaccinated dromedaries. J. Vet. Med. [B] Infect. Dis. 46(2), 131-136 (1999). • Describes the immunity to CMLV infection as well as to vaccination.
79. Khalafalla AI, El Dirdiri GA. Laboratory and feld investigations of a live attenuated and an inactivated camelpox vaccine. J. Camel Prac. Res. 10(2), 191-200 (2003).
80. Najarro P, Traktman P, Lewis JA. Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat 1 activation. J. Virol. 75(7), 3185-3196 (2001). •• Describes genes involved in immune evasion mechanisms and other host range functions.
81. Bowie A, Kiss-Toth E, Symons JA, Smith GL, Dower SK, O'Neill LA. A46R and A52R from vaccinia virus are antagonists of host IL-1 and Toll-like receptor signaling. Proc. Natl Acad. Sci. USA 97(18), 10162-10167 (2000).
82. Moss B, Shisler JL. Immunology 101 at poxvirus U: immune evasion genes. Semin. Immunol. 13(1), 59-66 (2001).
83. Perkus ME, Goebel SJ, Davis SW et al. Vaccinia virus host range genes. Virology 179(1), 276-286 (1990).
84. Kotwal GJ, Hugin AW, Moss B. Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13800-Da secreted protein. Virology 171(2), 579-587 (1989).
85. Betakova T, Wolffe EJ, Moss B. The vaccinia virus A14.5L gene encodes a hydrophobic 53-amino-acid virion membrane protein that enhances virulence in mice and is conserved among vertebrate poxviruses. J. Virol. 74(9), 4085-4092 (2000).
86. Barry M, Hnatiuk S, Mossman K, Lee SF, Boshkov L, McFadden G. The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. Virology 239(2), 360-377 (1997).
87. Senkevich TG, Wolffe EJ, Buller R M L. Ectromelia virus RING fnger protein is localized in virus factories and is required for virus replication in macrophages. J. Virol. 69(7), 4103-4111 (1995).
88. Mossman K, Lee SF, Barry M, Boshkov L, McFadden G. Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J. Virol. 70, 4394-4410 (1996).
89. Alcami A, Smith GL. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J. Virol. 69, 4633-4639 (1995).
90. Symons JA, Alcami A, Smith GL. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81, 551-560 (1995).
91. Alcami A, Symons JA, Collins PD, Williams TJ, Smith GL. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J. Immunol. 160, 624-633 (1998).
92. Alcami A, Khanna A, Paul NL, Smith GL. Vaccinia virus strains Lister, USSR and Evans express soluble and cell surface tumour necrosis factors receptor. J. Gen. Virol. 80, 949-959 (1999).
93. Blomquist MC, Hunt LT, Barker WC. Vaccinia virus 19-kilodalton protein: relationship several mammalian proteins, including two growth factors. Proc. Natl Acad. Sci. USA 81, 7363-7367 (1984).
94. Kotwal GJ, Isaacs SN, McKenzie R, Frank MM, Moss B. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250, 827-830 (1990).
95. Turner PC, Musy PY, Moyer RW. Poxvirus serpins. In: Viroceptors, Virokines and Related Immune Modulators Encoded by DNA Viruses. McFadden G (Ed.). RG Landes, TX, USA, 67-88 (1995).
96. Smith GL, Symons JA, Alcami A. Poxviruses; interfering with interferon. Semin. Virol. 8, 409-418 (1998).
97. Walter L, Marynen P, Szpirer J, Levan G, Gunther E. Identification of a novel conserved human gene, TEGT. Genomics 28, 301-304 (1995).
98. Kumar KN, Tilakaratne N, Johnson PS, Allen AE, Michaelis EK. Cloning of cDNA for the glutamate-binding subunit of an NMDA receptor complex. Nature 354, 70-73 (1991).
99. Xu Q, Reed JC. Bax inhibitor-1, a mammalian apoptosis suppressor identifed by functional screening in yeast. Molecular Cell 1, 337-346 (1998).
100. Kawai M, Pan L, Reed JC, Uchimiya H. Evolutionally conserved plant homologue of the Bax inhibitor-1 (BI-1) gene capable of suppressing Bax-induced cell death in yeast (1). FEBS Letters 464, 143-147 (1999).
101. Schwarz DA, Katayama CD, Hedrick SM. Schlafen, a new family of growth regulatory genes that affect thymocyte development. Immunity 9, 657-668 (1998).
102. Shchelkunov SN, Safronov PF, Totmenin AV et al. The genomic sequence analysis of the left and right species-specific terminal region of a cowpox virus strain reveals unique sequences and a cluster of intact ORFs for immunomodulatory and host range proteins. Virology 243, 432-460 (1998).
103. Eskra L, Mathison A, Splitter G. Microarray analysis of mRNA levels from RAW264.7 macrophages infected with Brucella abortus. Infect. Immun. 71, 1125-1133 (2003).
104. Geserick P, Kaiser F, Klemm U, Kaufmann SH, Zerrahn J. Modulation of T cell development and activation by novel members of the Schlafen (slfn) gene family harbouring an RNA helicase-like motif. Int. Immunol. 16, 1535-1548 (2004).
105. Alcami A, Symons JA, Khanna A, Smith GL. Poxviruses: capturing cytokines and chemokines. Semin. Virol. 8, 419-427 (1998).
106. Pfeffer M, Wernery U, Kaaden OR, Meyer H. Diagnostic procedures for poxvirus infections in camelids. J. Camel Pract. Res. 5(2), 189-195 (1998). •• Describes the different methods available for diagnosis of camelpox. (Pubitemid 128540528)
107. Wernery U. Viral infections in camels-a review. J. Camel Pract. Res. 2(1), 1-12 (1995).
108. Munz E, Otterbein CK, Meyer H, Renner I. A laboratory investigation to demonstrate a decreased virulence of two cell culture adapted African camelpox virus isolates as possible vaccine candidates. J. Camel Prac. Res. 4, 169-175 (1997). (Pubitemid 127531936)
109. Czerny CP, Meyer H, Mahnel H. Establishment of an ELISA for the detection of orthopoxviruses based on neutralizing monoclonal and polyclonal antibodies. J. Vet. Med. B Infect. Dis. Vet. Public Health 36, 537-546 (1989).
110. Johann S, Czerny CP. A rapid antigencapture ELISA for the detection of orthopoxviruses. J. Vet. Med. [B] 40, 569-581 (1993).
111. Balamurugan V, Bhanuprakash V, Hosamani M et al. A polymerase chain reaction strategy for the diagnosis of camelpox. J. Vet. Diagn. Invest. 21(2), 231-237 (2009). •• Describes CMLV-specific PCR-based on the C18L gene for detection and differentiation of CMLVfrom other OPXVs.
112. Sadykov RG. Cultivation of camelpox virus in chick embryos. In: Virusnye Bolezni Selskokhozayaystvennykh Zhivotnykh, Part I Moscow, 55 (1970) (In Russian).
113. Tantawi HH, El-Dahaby H, Fahmy LS. Comparative studies on poxvirus strains isolated from camels. Acta Virol. 22, 451-457 (1978).
114. El-Kenawy A, Abdel-Galil Y, El-Mekkawi M, Enany M. Studies on camel pox virus isolated from camels in Sharkia govemorate. J. Egyptian Vet. Med. Assoc. 49, 389-395 (1989).
115. Marodam V, Nagendrakumar SB, Tanwar VK et al. Isolation and identification of camelpox virus. Indian J. Animal Sci. 76, 326-327 (2006).
116. Marennikova SS. The results of examinations of wildlife monkeys for the presence of antibodies and viruses of the pox group. Vopr. Virusol. 3, 321-326 (1975).
117. Schgal CL. Camelpox. In: Report of Summer Institute on Animal Poxviruses. GB Pant University of Agriculture and Technology, India, 161-163 (1977).
118. Boulther EA, Zwartouw HT, Titmuss DH, Maber HB. The nature of the immune state produced by inactivated vaccinia virus in rabbits. Am. J. Epidem. 94, 612-618 (1971).
119. Marennikova SS, Malceva NN, Habahpaseva NA. ELISA-a simple test for detecting and differentiating antibodies to closely related orthopoxviruses. Bull World Health Organ. 59, 365-369 (1981).
120. Munz E, Schillinger D, Reimann M, Mahnel H. Electron microscopical diagnosis of Ecthyma contagiosum in camels (Camelus dromedarius): first report of the disease in Kenya. J. Vet. Med. B. 33, 73-77 (1986).
121. Munz E, Moallin AS, Mahnel H, Reimann M. Camel papillomatosis in Somalia. Zbl Vet. B. 37, 191-196 (1990).
122. Pfahler W H E, Reimann M, Munz E. A bitoin-avidin amplifed enzyme immunoassay for detection and quantitation of orthopox virus camel antibodies in dromedaries. J. Vet. Med. B. 33, 477-484 (1986).
123. Arita M, Tagaya I. Structural polypeptides of several strains of orthopoxvirus. Microbiol. Immun. 21, 343-346 (1977).
124. Esposito JJ, Obijeski JF, Nakano JH. The virion and soluble antigen proteins of variola, monkeypox and vaccinia viruses. J. Med. Virol. 1, 95-110 (1977).
125. November FJ, Raska K Jr, Holowczak JA. The immune response to vaccinia virus infection in mice: analysis of the role of antibody Arch. Virol. 107, 273-289 (1989).
126. Gubser C, Goodbody R, Ecker A et al. Camelpox virus encodes a Schlafen-like protein that affects orthopoxvirus virulence. J. Gen. Virol. 88(6), 1667-1676 (2007).
127. Sullivan JT, Mercer AA, Fleming SB, Robinson AJ. Identification and characterization of an orf virus homologue of the vaccinia virus gene encoding the major envelope protein p37K. Virology 202, 471-478 (1994).
128. Meyer H, Pfeffer M, Rziha HJ. Sequence alterations within and downstream of the A-type inclusion protein genes allow differentiation of Orthopoxvirus species by polymerase chain reaction. J. Gen. Virol 75, 1975-1981 (1994). • Most widely used PCR methods for diagnosis of OPXVs including CMLV.
129. Damaso CR, Esposito JJ, Condit RC, Moussatche N. An emergent poxvirus from humans and cattle in Rio de Janeiro state: Cantagalo virus may derive from Brazilian small pox vaccine. Virology 277, 439-449 (2000).
130. Lapa S, Mikheev M, Shchelkunov S et al. Species-level identification of orthopoxviruses with an oligonucleotide. Microchip J. Clin. Microbiol. 40, 753-757 (2002).
131. Sahay B. Evaluation of gene silencing by RNA interference (RNAi) in control of animal virus infections. PhD thesis. Deemed University, IVRI, Izatnagar, India (2006).
132. Khalafalla AI, Buttner M, Rziha HJ. Polymerase chain reaction (PCR) for rapid diagnosis and differentiation of para-and orthopox virus infections in camels. FAO/IAEA International Animal Production and Health in Developing Countries, 6-10 October 2003, Vienna, Austria (2003).
133. Ropp SL, Jin Q, Knight JC, Massung RF, Esposito JJ. PCR strategy for identification and differentiation of small pox and other orthopoxviruses. J. Clin. Microbiol. 33, 2069-2076 (1995).
134. Huemer HP, Honlinger B, Hopf R. A simple restriction fragment PCR approach for discrimination of human pathogenic old world animal orthopoxvirus species. Can. J. Microbiol. 54, 159-162 (2008).
135. Panning M, Asper M, Kramme S, Schmitz H, Drosten C. Rapid detection and differentiation of human pathogenic orthopox viruses by a fuorescence resonance energy transfer real-time PCR assay. Clin. Chem. 50, 702-708 (2004).
136. Nitsche A, Ellerbrok H, Pauli, G. Detection of orthopoxvirus DNA by real-time PCR and variola virus DNA by melting analysis. J. Clin. Microbiol. 42(3), 1207-1213 (2004).
137. De Clercq E. Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections. Clin. Microbiol. Rev. 14(2), 382-397 (2001).
138. Snoeck R, Andrei G, De Clercq E. Therapy of poxvirus infections. In: Poxviruses. Mercer AA, Schmidt A, Weber O (Eds), Birkhaüser, Basel, Switzerland, 375-395 (2007).
139. Sliva K, Schnierle B. From actually toxic to highly specific-novel drugs against poxviruses. Virol. J. 4, 8 (2007).
140. Xiong X, Smith JL, Kim C, Huang E, Chen MS. Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase. Biochem. Pharmacol. 51, 1563-1567 (1996).
141. Smee DF, Sidwell RW, Kefauver D, Bray M, Huggins JW. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses. Antimicrob. Agents Chemother. 46, 1329-1335 (2002).
142. Andrei G, Gammon DB, Fiten P et al. Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice. J. Virol. 80(19), 9391-9401 (2008).
143. Kornbluth RS, Smee DF, Sidwell RW, Snarsky V, Evans DH, Hostetler KY. Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype. Antimicrob. Agents Chemother. 50(12), 4038-4043 (2006).
144. Gammon DB, Snoeck R, Fiten P et al. Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs. J. Virol. 82(24), 12520-12534 (2008).
145. Yang G, Pevear DC, Davies MH et al. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge. J. Virol. 79(20), 13139-13149 (2005).
146. Berhanu A, King DS, Mosier S et al. ST-246 inhibits in vivo poxvirus dissemination, virus shedding, and systemic disease manifestation. Antimicrob. Agents Chemother. 53(12), 4999-5009 (2009).
147. Jordan R, Tien D, Bolken TC et al. Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitor. Antimicrob Agents Chemother. 52(5), 1721-1727 (2008).
148. Grosenbach DW, Jordan R, King DS et al. Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination. Vaccine 26(7), 933-946 (2008).
149. Quenelle DC, Prichard MN, Keith KA et al. Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses, Antimicrob. Agents Chemother. 51(11), 4118-4124 (2007).
150. Samartsev AA, Praksein ST. Camelpox study. Proc. Kazakh. Res. Vet. Institute 5, 198-200 (1950).
151. Buchnev KN, Sadykov RG. Contribution to the study of camelpox. Proceedings of the 3rd All-Union Conference on Virology, Part II, 152-153 (1967).
152. Sedov VA. Offcial communication: measure for the prevention and eradication of camelpox. Veterinariya (Moscow) 44, 295 12, 63-64 (1974). •• Introduces the concept of vaccination against camelpox.
153. Krupenko SS. Camelpox caused by vaccinia virus. Veterinariya (Moscow) No. 8, 61-62 (Ru) (1973).
154. Higgins AJ. The camel in health and disease. Bailliere Tindall, London, UK, 168 (1986).
155. Mayr A, Eissner G, Mayr-Bibrack B. Handbuch der Schutzimpfungen in der Tiermedizin. Paul Parey, Berlin, Germany, 739 (1984).
156. Mayr A. Geschichtlicher Uberblick uberdie Menschenpocken (Variola), die Eradikation von Variola und den attenuierten Pockenstamm MVA. Berl. Munch. Tierarzil. Wschr. 112, 322-328 (1999).
157. El-Harrak M, Loutf C, Bertin F. Isolement et identification du virus de la variole du dromadaire au Maroc. Ann. Rech. Vet. 22, 95-98 (1991).
158. El-Harrak M. Isolation of camlepox virus, development of an inactivated vaccine and prophylactic application in Morocco. Presented at: Ins. Meeting on Camel Production and Future Perspectives. Al Ain, UAE, May 2-3, 736 (1998).
159. Wernery U, Kaaden OR. Infectious diseases of camels. Blackwell Scientifc, Oxford, UK (1995).
160. Wernery U, Kinne J, Zachariah R. Experimental camelpox infection in vaccinated and unvaccinated guanacos, J. Camel Pract. Res. 7(2), 149-152 (2000).
161. Klopries M. Etablierung und Charakterisierung einer Kamelhautzellinie (Dubca). Vet. Med. Dissertation Munchen, Germany (1993).
162. Kaaden OR, Wernery U, Klopries M. Camel fbroblast cell line Dubca and its use for diagnosis and prophylaxis of camel diseases. Presented at: The International Conference on Livestock Production in Hot Climates. Muscat, Oman, A49 (1995).
163. De Clercq E. Cidofovir in the treatment of poxvirus infections. Antivir. Res. 55, 1-13 (2002).
164. Bera BC, Gnanavel V, Barua S et al. Zoonotic camelpox infections in India. Abstract: International Conference on 'Protecting Animal Health: Facilitating Trade in Livestock and Livestock Products' IAVMI, India, January 27-29, 197 (2010). •• States the possibility of zoonotic infection, but needs further thorough investigation.
165. Funahashi S, Sato T, Shida H. Cloning and characterization of the gene encoding the major protein of the A-type inclusion body of cowpox virus. J. Gen. Virol. 69, 35-47 (1988).
166. Meyer H, Rziha HJ. Characterization of the gene encoding the A-type inclusion protein of camelpox virus and sequence comparison with other orthopoxviruses. J. Gen. Virol. 74, 1679-1684 (1993).